Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects

Cell Reports

Volumn 8, Issue 3, 2014, Pages 767-782

  Wang, Chelsia Qiuxia ^a,b   Krishnan, Vaidehi ^a   Tay, Lavina Sierra ^a   Chin, Desmond Wai Loon ^a   Koh, Cai Ping ^a   Chooi, Jing Yuan ^a   Nah, Giselle Sek Suan ^a,b   Du, Linsen ^a   Jacob, Bindya ^a   Yamashita, Namiko ^a   Lai, Soak Kuan ^a   Tan, Tuan Zea ^a   Mori, Seiichi ^a   Tanuichi, Ichiro ^c   Tergaonkar, Vinay ^b   Ito, Yoshiaki ^a,b   Osato, Motomi ^a,b,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c Institute of Physical and Chemical Research   (Japan)

^d INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA GROUP D2 PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; DNA REPAIR; FANCONI ANEMIA; HEMATOPOIETIC STEM CELL; LEUKEMIA; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION;

MUS;

EID: 84924538729     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.046     Document Type: Article

References (40)

1. Banerji, S., Cibulskis, K., Rangel-Escareno, C., Brown, K.K., Carter, S.L., Frederick, A.M., Lawrence, M.S., Sivachenko, A.Y., Sougnez, C., Zou, L., et al. (2012). Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405-409.
2. Bunting, S.F., Callén, E., Kozak, M.L., Kim, J.M., Wong, N., López-Contreras, A.J., Ludwig, T., Baer, R., Faryabi, R.B., Malhowski, A., et al. (2012). BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol. Cell 46, 125-135.
3. Byrd, R.S., Zwerdling, T., Moghaddam, B., Pinter, J.D., and Steinfeld, M.B. (2011). Monosomy 21q22.11-q22.13 presenting as a Fanconi anemia phenotype. Am. J. Med. Genet. A. 155A, 120-125.
4. Cain, C.J., and Manilay, J.O. (2013). Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: comparisons and current controversies. Exp. Hematol. 41, 3-16.
5. Callen, E., Di Virgilio, M., Kruhlak, M.J., Nieto-Soler, M., Wong, N., Chen, H.T., Faryabi, R.B., Polato, F., Santos, M., Starnes, L.M., et al. (2013). 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions. Cell 153, 1266-1280.
6. Carey, L.A., and Sharpless, N.E. (2011). PARP and cancer-if it's broke, don't fix it. N. Engl. J. Med. 364, 277-279.
7. Cheng, C.K., Li, L., Cheng, S.H., Lau, K.M., Chan, N.P., Wong, R.S., Shing, M.M., Li, C.K., and Ng, M.H. (2008). Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia. Blood 112, 3391-3402.
8. Chuang, L.S., Lai, S.K., Murata-Hori, M., Yamada, A., Li, H.Y., Gunaratne, J., and Ito, Y. (2012). RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors. Cell Cycle 11, 1938-1947.
9. Click, E.S., Cox, B., Olson, S.B., Grompe, M., Akkari, Y., Moreau, L.A., Shimamura, A., Sternen, D.L., Liu, Y.J., Leppig, K.A., et al. (2011). Fanconi anemialike presentation in an infant with constitutional deletion of 21q including the RUNX1 gene. Am. J. Med. Genet. A. 155A, 1673-1679.
10. Dao, K.H., Rotelli, M.D., Petersen, C.L., Kaech, S., Nelson, W.D., Yates, J.E., Hanlon Newell, A.E., Olson, S.B., Druker, B.J., and Bagby, G.C. (2012). FANCL ubiquitinates b-catenin and enhances its nuclear function. Blood 120, 323-334.
11. Ellisen, L.W. (2011). PARP inhibitors in cancer therapy: promise, progress, and puzzles. Cancer Cell 19, 165-167.
12. Eppert, K., Takenaka, K., Lechman, E.R., Waldron, L., Nilsson, B., van Galen, P., Metzeler, K.H., Poeppl, A., Ling, V., Beyene, J., et al. (2011). Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17, 1086-1093.
13. Ito, Y. (2008). RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv. Cancer Res. 99, 33-76.
14. Ito, K., Lim, A.C., Salto-Tellez, M., Motoda, L., Osato, M., Chuang, L.S., Lee, C.W., Voon, D.C., Koo, J.K., Wang, H., et al. (2008). RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14, 226-237.
15. Jacob, B., Osato, M., Yamashita, N., Wang, C.Q., Taniuchi, I., Littman, D.R., Asou, N., and Ito, Y. (2010). Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood 115, 1610-1620.
16. Kee, Y., and D'Andrea, A.D. (2010). Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 24, 1680-1694.
17. Kim, J.M., Parmar, K., Huang, M., Weinstock, D.M., Ruit, C.A., Kutok, J.L., and D'Andrea, A.D. (2009). Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev. Cell 16, 314-320.
18. Kumari, U., Ya Jun, W., Huat Bay, B., and Lyakhovich, A. (2014). Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene 33, 165-172.
19. Lee, Y.S., Lee, J.W., Jang, J.W., Chi, X.Z., Kim, J.H., Li, Y.H., Kim, M.K., Kim, D.M., Choi, B.S., Kim, E.G., et al. (2013). Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma. Cancer Cell 24, 603-616.
20. Ley, T.J., Miller, C., Ding, L., Raphael, B.J., Mungall, A.J., Robertson, A.G., Hoadley, K., Triche, T.J., Laird, P.W., Baty, J.D., et al.; Cancer Genome Atlas Research Network (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059-2074.
21. Liu, P., Tarlé, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J., and Collins, F.S. (1993). Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261, 1041-1044.
22. Maddipoti, S.C., Bueso-Ramos, C., Yang, H., Fernandez, M., Kuang, S., Fang, Z., Stevenson, W., Wei, Y., Pierce, S., and Garcia-Manero, G. (2008). Epigenetic silencing of the RUNX3 gene by promoter hypermethylation in patients with acute myeloid leukemia. Blood 112, 3341-3341.
23. Mason, J.M., and Sekiguchi, J.M. (2011). Snm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks. Hum. Mol. Genet. 20, 2549-2559.
24. Meyers, S., Lenny, N., Sun, W., and Hiebert, S.W. (1996). AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13, 303-312.
25. Moldovan, G.L., and D'Andrea, A.D. (2009). How the fanconi anemia pathway guards the genome. Annu. Rev. Genet. 43, 223-249.
26. Mosca, L., Musto, P., Todoerti, K., Barbieri, M., Agnelli, L., Fabris, S., Tuana, G., Lionetti, M., Bonaparte, E., Sirchia, S.M., et al. (2013). Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles. Am. J. Hematol. 88, 16-23.
27. Motoda, L., Osato, M., Yamashita, N., Jacob, B., Chen, L.Q., Yanagida, M., Ida, H., Wee, H.J., Sun, A.X., Taniuchi, I., et al. (2007). Runx1 protects hematopoietic stem/progenitor cells from oncogenic insult. Stem Cells 25, 2976-2986.
28. Nakanishi, K., Yang, Y.G., Pierce, A.J., Taniguchi, T., Digweed, M., D'Andrea, A.D., Wang, Z.Q., and Jasin, M. (2005). Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. USA 102, 1110-1115.
29. Naoe, Y., Setoguchi, R., Akiyama, K., Muroi, S., Kuroda, M., Hatam, F., Littman, D.R., and Taniuchi, I. (2007). Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer. J. Exp. Med. 204, 1749-1755.
30. Osato, M. (2004). Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 23, 4284-4296.
31. Parmar, K., Kim, J., Sykes, S.M., Shimamura, A., Stuckert, P., Zhu, K., Hamilton, A., Deloach, M.K., Kutok, J.L., Akashi, K., et al. (2010). Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1. Stem Cells 28, 1186-1195.
32. Pulliam-Leath, A.C., Ciccone, S.L., Nalepa, G., Li, X., Si, Y., Miravalle, L., Smith, D., Yuan, J., Li, J., Anur, P., et al. (2010). Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia. Blood 116, 2915-2920.
33. Speck, N.A., and Gilliland, D.G. (2002). Core-binding factors in haematopoiesis and leukaemia. Nat. Rev. Cancer 2, 502-513.
34. Taniuchi, I., Osato, M., Egawa, T., Sunshine, M.J., Bae, S.C., Komori, T., Ito, Y., and Littman, D.R. (2002). Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621-633.
35. Vandenberg, C.J., Gergely, F., Ong, C.Y., Pace, P., Mallery, D.L., Hiom, K., and Patel, K.J. (2003). BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12, 247-254.
36. Wang, H., Fan, R., Wang, X.Q., Wu, D.P., Lin, G.W., Xu, Y., and Li, W.Y. (2013a). Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome. Ann. Hematol. 92, 199-209.
37. Wang, C.Q., Motoda, L., Satake, M., Ito, Y., Taniuchi, I., Tergaonkar, V., and Osato, M. (2013b). Runx3 deficiency results in myeloproliferative disorder in aged mice. Blood 122, 562-566.
38. Yamamoto, K., Hirano, S., Ishiai, M., Morishima, K., Kitao, H., Namikoshi, K., Kimura, M., Matsushita, N., Arakawa, H., Buerstedde, J.M., et al. (2005). Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell. Biol. 25, 34-43.
39. Yano, T., Ito, K., Fukamachi, H., Chi, X.Z., Wee, H.J., Inoue, K., Ida, H., Bouillet, P., Strasser, A., Bae, S.C., and Ito, Y. (2006). The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol. Cell. Biol. 26, 4474-4488.
40. Zaidi, S.K., Sullivan, A.J., van Wijnen, A.J., Stein, J.L., Stein, G.S., and Lian, J.B. (2002). Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc. Natl. Acad. Sci. USA 99, 8048-8053.